Skip to main content

Table 1 Clinical features of patients with fibrostenosing Crohn’s disease (n=29)

From: The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

Characteristics and parameters n Median (range)
Age, years   35.8 (23 to 61)
First attack 6  
Intestinal location   
 Small bowel and colon 15  
 Small bowel only 9  
 Colon only 5  
Duration of disease, months   81.2 (7 to 196)
Number of recurrences   4 (0 to 9)
CDAI   223 (155 to 426)
Treatment   
 Mesalazine 13  
 Topical steroids 3  
 Antibiotics 9  
 Azathioprine/6-MP/methotrexate 14  
  1. Abbreviations: CDAI Crohn’s Disease Activity Index, 6-MP 6-mercaptopurine.